Flavoxate hydrochloride is a synthetic urinary tract spasmolytic agent that functions as an anticholinergic and antimuscarinic drug, commonly prescribed to treat conditions such as interstitial cystitis,… Read more





Flavoxate hydrochloride is a synthetic urinary tract spasmolytic agent that functions as an anticholinergic and antimuscarinic drug, commonly prescribed to treat conditions such as interstitial cystitis, dysuria, urgency, and nocturia. Ensuring the safety and efficacy of this medication requires rigorous analytical testing, for which pharmaceutical laboratories rely on high-quality reference standards. This category encompasses the active pharmaceutical ingredient alongside a selection of related impurities, including pharmacopeial and non-pharmacopeial compounds often identified during synthesis or stability monitoring. These impurity profiling standards are essential for validating analytical methods and ensuring compliance with regulatory quality control requirements. Additionally, stable isotope labelled compounds are available to serve as internal standards in quantitative analysis, allowing researchers to improve the accuracy and precision of assays while conducting impurity identification and purity verification throughout the pharmaceutical development process.